Endo-TAGSS — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Endo-TAGSS is a private, pre-revenue medical device company founded in 2016 and based in San Diego, CA, USA. Its core technology is the TAGSS device, a 12mm trans-abdominal gastric port system intended to bridge the gap between endoscopy and laparoscopy, allowing for more complex intragastric surgeries with fewer incisions and potentially lower costs. The company is in the pre-clinical stage, having demonstrated proof-of-concept in animal models for applications like pyloroplasty and fundoplication, but its devices are not yet FDA-cleared for sale.

GastroenterologyOncologyMetabolic Disorders

Technology Platform

Trans-Abdominal Gastric Surgical System (TAGSS), a percutaneous 12mm port device placed like a PEG tube to enable intragastric surgery with standard laparoscopic instruments.

Opportunities

The TAGSS device addresses a clear gap between endoscopy and laparoscopy, targeting a large market of GI disorders with a potentially more cost-effective and less invasive outpatient procedure.

Its platform nature allows it to pursue multiple high-volume indications (e.g., GERD, obesity) with a single regulatory clearance, maximizing potential market impact.

Risk Factors

The company is pre-revenue and pre-FDA clearance, facing significant regulatory, clinical validation, and financing risks.

Commercial adoption is uncertain, as it requires surgeons to learn a new technique and may face competition from evolving endoscopic tools and established laparoscopic approaches.

Competitive Landscape

Competition includes advanced therapeutic endoscopy platforms (e.g., through-the-scope devices, endoscopic suturing) and single-incision laparoscopic surgery (SILS) ports. Endo-TAGSS differentiates by specifically enabling multi-instrument triangulation directly into the stomach via a PEG-like access point, a hybrid approach not directly offered by current market leaders in either field.

More companies in Drug Delivery & Formulation →More companies in United States →